Table 3 Dynamics of prescription changes during the hay fever season
N (%) | 2009 (n=25,069) | 2010 (n=22,381) | ||||||
|---|---|---|---|---|---|---|---|---|
SAR (n=18,341) | NSUAD (n=6,728) | SAR (n=16,187) | NSUAD (n=6,194) | |||||
Season start | Season end | Season start | Season end | Season start | Season end | Season start | Season end | |
Monotherapy | 12,289 (67.0) | 10,136 (55.3) | 5,181 (77.0) | 3,130 (46.5) | 10,776 (66.6) | 8,850 (54.7) | 4,764 (76.9) | 2,974 (48.0) |
Dual therapy | 4,314 (23.5) | 5,892 (32.1) | 1,265 (18.8) | 2,741 (40.7) | 3,782 (23.4) | 5,213 (32.2) | 1,172 (18.9) | 2,445 (39.5) |
Triple therapy | 1,717 (9.4) | 2,243 (12.2) | 272 (4.0) | 755 (11.2) | 1,615 (10.0) | 2,062 (12.7) | 244 (3.9) | 694 (11.2) |
4 therapies | 20 (0.1) | 68 (0.4) | 10 (0.2) | 92 (1.4) | 24 (0.2) | 62 (0.4) | 14 (0.2) | 77 (1.2) |
5 therapies | 1 (0.0) | 2 (0.0) | 0 (0.0) | 9 (0.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (0.1) |
Total multiple therapies | 6,052 (33.0) | 8,205 (44.7) | 1,547 (23.0) | 3,598 (53.5) | 5,421 (33.5) | 7,337 (45.3) | 1,430 (23.1) | 3,220 (52.0) |
Multiple therapies prescribed by season end | ||||||||
OAH+INS | 2,938 (16.0) | 1,448 (21.5) | 2,590 (16.0) | 1,278 (20.6) | ||||
OAH+INS+ED | 2,026 (11.0) | 466 (6.9) | 1,894 (11.7) | 453 (7.3) | ||||
OAH+ED | 2,086 (11.4) | 479 (7.1) | 1,882 (11.6) | 453 (7.3) | ||||
INS+ED | 385 (2.1) | 143 (2.1) | 335 (2.1) | 127 (2.1) | ||||
Other | 770 (4.2) | 1,062 (15.8) | 636 (3.9) | 909 (14.7) | ||||
